Literature DB >> 23128866

Cardiovascular effects of diabetes drugs: emerging from the dark ages.

Steven E Nissen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23128866     DOI： 10.7326/0003-4819-157-9-201211060-00016

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  9 in total

Review 1.  Treatment of type 2 diabetes, lifestyle, GLP1 agonists and DPP4 inhibitors.

Authors:  Gerald H Tomkin
Journal:  World J Diabetes       Date:  2014-10-15

2.  Frailty Attenuates the Impact of Metformin on Reducing Mortality in Older Adults with Type 2 Diabetes.

Authors:  Chen-Pin Wang; Carlos Lorenzo; Sara E Espinoza
Journal:  J Endocrinol Diabetes Obes       Date:  2014

3.  Metformin in peritoneal dialysis: a pilot experience.

Authors:  Abdulla Khalaf Al-Hwiesh; Ibrahiem Saeed Abdul-Rahman; Mohammad Ahmad Nasr El-Deen; Emmanuel Larbi; Jose C Divino-Filho; Fahd Abdul-Aziz Al-Mohanna; Krishan L Gupta
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

4.  Lessons From a Diabetes Clinic: Achieving Glycemic Goals and Clinical Use of Antidiabetic Agents in Patients With Type 2 Diabetes.

Authors:  Iakovos Avramidis; Athanasia Apsemidou; Antigoni Z Lalia; Nikolaos Petridis; Euangelos Tourtouras; Georgios Kalopitas; Georgios Pilianidis
Journal:  Clin Diabetes       Date:  2020-07

5.  Estimating the incremental net health benefit of requirements for cardiovascular risk evaluation for diabetes therapies.

Authors:  Anita J Chawla; Daniel S Mytelka; Stephan D McBride; Dave Nellesen; Benjamin R Elkins; Daniel E Ball; Anupama Kalsekar; Adrian Towse; Louis P Garrison
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-01-14       Impact factor: 2.890

6.  Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studies.

Authors:  Manel Pladevall; Nuria Riera-Guardia; Andrea V Margulis; Cristina Varas-Lorenzo; Brian Calingaert; Susana Perez-Gutthann
Journal:  BMC Cardiovasc Disord       Date:  2016-01-15       Impact factor: 2.298

Review 7.  The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials.

Authors:  Dimitris Varvaki Rados; Lana Catani Pinto; Luciana Reck Remonti; Cristiane Bauermann Leitão; Jorge Luiz Gross
Journal:  PLoS Med       Date:  2016-04-12       Impact factor: 11.069

8.  Treated glycosylated hemoglobin levels in individuals with diabetes mellitus vary little by health status: A retrospective cohort study.

Authors:  Finlay A McAlister; Erik Youngson; Dean T Eurich
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

Review 9.  Evaluating cardiovascular safety of novel therapeutic agents for the treatment of type 2 diabetes mellitus.

Authors:  Sidra Azim; William L Baker; William B White
Journal:  Curr Cardiol Rep       Date:  2014-11       Impact factor: 2.931
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.